Literature DB >> 2418122

Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies.

F K Stevenson, A J George, M T Walters, T J Hamblin.   

Abstract

A quantitative assay for soluble human HLA Class II antigenic material is described. The method is a double-determinant ELISA using 2 monoclonal antibodies which recognize different epitopes on the antigen. The first rat monoclonal antibody captures antigen onto the microplate where it is then recognized by a second mouse monoclonal antibody. Bound mouse immunoglobulin is then detected by an enzyme-linked rat polyclonal antibody. The assay has been used to measure soluble HLA Class II antigen in the sera from healthy individuals and patients with leukaemia, and has shown raised levels in acute lymphoblastic but not in chronic lymphocytic leukaemia. Similar material has been identified in synovial fluid of patients with active rheumatoid arthritis. The assay is specific and simple to perform and should be applicable to probing the nature of the soluble material and its mechanism of release.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2418122     DOI: 10.1016/0022-1759(86)90451-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

Review 1.  Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients.

Authors:  Irena Adamashvili; Roger E Kelley; Thomas Pressly; John C McDonald
Journal:  Rheumatol Int       Date:  2005-06-29       Impact factor: 2.631

Review 2.  Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigens.

Authors:  Katerina Bakela; Irene Athanassakis
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

3.  An investigation of the action of disease modifying antirheumatic drugs on the rheumatoid synovial membrane: reduction in T lymphocyte subpopulations and HLA-DP and DQ antigen expression after gold or penicillamine therapy.

Authors:  M T Walters; J L Smith; K Moore; P R Evans; M I Cawley
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

4.  Mate choice decisions of stickleback females predictably modified by MHC peptide ligands.

Authors:  Manfred Milinski; Siân Griffiths; K Mathias Wegner; Thorsten B H Reusch; Annette Haas-Assenbaum; Thomas Boehm
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-08       Impact factor: 11.205

5.  Soluble histocompatibility antigens in synovial fluids of patients with rheumatoid arthritis.

Authors:  F K Stevenson; W A Douglass; M B Spellerberg; M T Walters; M I Cawley
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

6.  MHC class I and class II antigen expression in normal human corneas and in corneas from cases of herpetic keratitis.

Authors:  B W McBride; J I McGill; J L Smith
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

7.  Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study.

Authors:  Irena Adamashvili; Alireza Minagar; Eduardo Gonzalez-Toledo; Liubov Featherston; Roger E Kelley
Journal:  J Neuroinflammation       Date:  2005-06-02       Impact factor: 8.322

8.  Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics.

Authors:  Annemijn P A Wierenga; Gülçin Gezgin; Els van Beelen; Michael Eikmans; Marijke Spruyt-Gerritse; Niels J Brouwer; Mieke Versluis; Robert M Verdijk; Sjoerd G van Duinen; Marina Marinkovic; Gregorius P M Luyten; Martine J Jager
Journal:  Cancers (Basel)       Date:  2019-08-18       Impact factor: 6.639

9.  Saliva soluble HLA as a potential marker of response to interferon-beta 1a in multiple sclerosis: a preliminary study.

Authors:  Alireza Minagar; Irena Adamashvili; Roger E Kelley; Eduardo Gonzalez-Toledo; Jerry McLarty; Stacy J Smith
Journal:  J Neuroinflammation       Date:  2007-07-01       Impact factor: 8.322

10.  Phenotypic and genotypic heterogeneity of peripheral T-cell lymphoma.

Authors:  J L Smith; D G Haegert; E Hodges; G N Stacey; W M Howell; D H Wright; D B Jones
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.